1. Market Research
1-30 of About 1600 reports for DelveInsight

Purchase Reports From Reputable Market Research Publishers

Autism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Autism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Opioid-Induced Constipation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Opioid-Induced Constipation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Fabry Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Fabry Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 1500
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Metastatic Renal Cell Carcinoma (mRCC) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Metastatic Renal Cell Carcinoma (mRCC) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Alopecia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Alopecia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Chronic Liver Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Chronic Liver Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Peptic Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Peptic Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 1500
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Hereditary Angioedema - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Hereditary Angioedema - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 1500
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Short Bowel Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Short Bowel Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 1500
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Malignant Glioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Malignant Glioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Hemophilia B - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Hemophilia B - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Esophageal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Esophageal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Digestive System Disorder
  • Pathology
  • World
  • Demand
  • Product Initiative
Spinal Muscular Atrophy (SMA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Spinal Muscular Atrophy (SMA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 1500
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Post-Traumatic Stress Disorder (PTSD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Post-Traumatic Stress Disorder (PTSD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Anxiety Disorder
  • Mental Health
  • Pathology
  • World
  • Product Initiative
Chronic Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Chronic Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Sickle Cell Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Sickle Cell Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Premature Labor (Tocolysis) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Premature Labor (Tocolysis) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 1500
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Indolent Lymphoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Indolent Lymphoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Idiopathic Pulmonary Fibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Idiopathic Pulmonary Fibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Otitis Media - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Otitis Media - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 1500
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Polycystic Kidney Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Polycystic Kidney Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 1500
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Optic Neuritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Optic Neuritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Raynauds Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Raynauds Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Bacterial Vaginosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Bacterial Vaginosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Varicose Veins - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Varicose Veins - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 1500
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 1500
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative
Hepatitis D - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Hepatitis D - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 1500
  • November 2017
  • by Delve Insight
  • About DelveInsight
  • DelveInsight Report Introduction
  • Publishing
  • World
  • Demand
  • Product Initiative

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.